Imugene Ltd
Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more
Imugene Ltd (IMU) - Total Liabilities
Latest total liabilities as of December 2025: AU$25.80 Million AUD
Based on the latest financial reports, Imugene Ltd (IMU) has total liabilities worth AU$25.80 Million AUD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Imugene Ltd - Total Liabilities Trend (1993–2025)
This chart illustrates how Imugene Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Imugene Ltd Competitors by Total Liabilities
The table below lists competitors of Imugene Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AVTECH Sweden AB Series B
ST:AVT-B
|
Sweden | Skr5.20 Million |
|
Altair Minerals Ltd
AU:ALR
|
Australia | AU$253.97K |
|
Novem Group S.A.
F:NVM
|
Germany | €447.80 Million |
|
Simula Technology
TWO:3511
|
Taiwan | NT$586.40 Million |
|
Casino Guichard Perrachon SA
PA:CO
|
France | €6.62 Billion |
|
Rabbit Holdings PCL
BK:RABBIT
|
Thailand | ฿31.34 Billion |
|
Al-Salam Real Estate Investment Trust
KLSE:5269
|
Malaysia | RM662.78 Million |
|
PTL LTD Ordinary Shares
NASDAQ:PTLE
|
USA | $551.64K |
Liability Composition Analysis (1993–2025)
This chart breaks down Imugene Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Imugene Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Imugene Ltd (1993–2025)
The table below shows the annual total liabilities of Imugene Ltd from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$38.56 Million | +16.33% |
| 2024-06-30 | AU$33.14 Million | +345.66% |
| 2023-06-30 | AU$7.44 Million | -16.45% |
| 2022-06-30 | AU$8.90 Million | +31.06% |
| 2021-06-30 | AU$6.79 Million | +25.80% |
| 2020-06-30 | AU$5.40 Million | +54.93% |
| 2019-06-30 | AU$3.48 Million | +142.19% |
| 2018-06-30 | AU$1.44 Million | +12.15% |
| 2017-06-30 | AU$1.28 Million | -23.60% |
| 2016-06-30 | AU$1.68 Million | +21.45% |
| 2015-06-30 | AU$1.38 Million | -27.20% |
| 2014-06-30 | AU$1.90 Million | +172.09% |
| 2013-06-30 | AU$698.03K | +184.94% |
| 2012-06-30 | AU$244.97K | -48.99% |
| 2011-06-30 | AU$480.28K | +56.25% |
| 2010-06-30 | AU$307.37K | -29.62% |
| 2009-06-30 | AU$436.72K | -11.48% |
| 2008-06-30 | AU$493.37K | -11.99% |
| 2007-06-30 | AU$560.55K | -30.46% |
| 2006-06-30 | AU$806.04K | +95.87% |
| 2005-06-30 | AU$411.52K | -29.57% |
| 2004-06-30 | AU$584.29K | -16.62% |
| 2003-06-30 | AU$700.77K | +1259.15% |
| 2002-06-30 | AU$51.56K | -98.07% |
| 2001-06-30 | AU$2.67 Million | +195.33% |
| 2000-06-30 | AU$903.09K | +0.57% |
| 1999-06-30 | AU$898.00K | -20.95% |
| 1998-06-30 | AU$1.14 Million | -8.46% |
| 1997-06-30 | AU$1.24 Million | +10.12% |
| 1996-06-30 | AU$1.13 Million | -13.64% |
| 1995-06-30 | AU$1.30 Million | +927.56% |
| 1994-06-30 | AU$127.00K | -78.36% |
| 1993-06-30 | AU$587.00K | -- |